You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Aptapharma Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for APTAPHARMA INC, and what generic and branded alternatives to APTAPHARMA INC drugs are available?

APTAPHARMA INC has five approved drugs.



Summary for Aptapharma Inc
US Patents:0
Tradenames:5
Ingredients:5
NDAs:5

Drugs and US Patents for Aptapharma Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aptapharma Inc CHLORZOXAZONE chlorzoxazone TABLET;ORAL 212053-002 Sep 14, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Aptapharma Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride SOLUTION;ORAL 216953-001 Nov 15, 2022 AA RX No No ⤷  Try a Trial ⤷  Try a Trial
Aptapharma Inc SILDENAFIL CITRATE sildenafil citrate FOR SUSPENSION;ORAL 213041-001 Aug 6, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Aptapharma Inc CHLORZOXAZONE chlorzoxazone TABLET;ORAL 212053-001 Sep 14, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Aptapharma Inc IBUPROFEN ibuprofen SUSPENSION;ORAL 210602-001 Nov 23, 2018 OTC No No ⤷  Try a Trial ⤷  Try a Trial
Aptapharma Inc OSELTAMIVIR PHOSPHATE oseltamivir phosphate FOR SUSPENSION;ORAL 212858-001 Aug 30, 2021 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.